Navigation Links
GlaxoSmithKline Signs Outsourcing Deal With TCS

GlaxoSmithKline (GSK), Britain's largest drug company, // has signed an outsourcing deal with India's Tata Consulting Services to establish a drug development support facility in Mumbai.

A company statement said that under the terms of the deal, TCS will support GSK's global clinical research and development programme by providing outsourced data management and medical trial reporting services.

The arrangement will create nearly 100 new jobs on an existing site and reports say that the deal is understood to be worth more than £ 10 million.

GSK already has sizeable research operations in Mumbai and Bangalore and employs 2,400 people in India, where it controls 5.9 per cent of the pharmaceuticals market, The Times said.

Amber Salzman, senior vice-president of development operations at GSK, said in a statement that the company had picked TCS as a partner because of its strong record in knowledge process outsourcing and operational excellence.

Like many global companies GSK has been seeking to tap into India's pool of high-quality IT and scientific talent and is aiming to trim costs through outsourcing.

GSK is also involved in research collaboration with India's Ranbaxy Laboratories, to jointly develop drugs in areas such as urology, diabetes and asthma. Earlier this year, GSK announced that pre-tax profits rose 16 per cent in 2006 to £ 7.8 billion on the previous year, on turnover of £ 23.2 billion. br>
Source-IANS
SM
'"/>




Page: 1

Related medicine news :

1. GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging
2. GlaxoSmithKline To Cultivate Non-Smoking Environment
3. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
4. FDA Mislead On Asthma Drug By GlaxoSmithKline
5. GlaxoSmithKline Defends Its Products
6. GlaxoSmithKline launches diabetes and cancer drugs
7. Generic Products Compete With GlaxoSmithKline
8. GlaxoSmithKline Agrees To Settle Paxil Claims For $14 million
9. GlaxoSmithKlines Zofran Helps In Treatment Of Dehydration In Children
10. GlaxoSmithKline’s Epilepsy Drug given the Green Signal by FD
11. GlaxoSmithKline’s Tykerb is to Be Started Earlier in Breast Cancer, Study Find
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, the game-changing dual ... opening of the Sober College Robert Pfeifer Memorial Learning Center at its location ... was attended by an overwhelming amount of alumni, family, colleagues and friends of ...
(Date:12/9/2016)... ... ... "I had a terrible time trying to get my grandson to use his ... had a more child-friendly design, then children would be more likely to look forward ... avoid the need to deliver medication via a nebulizer mask. The design will not ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Company LLC, announced the first national #QuackGivesBack campaign which supported local breast ... was our first franchise-wide Quack Gives Back initiative, and we’re very ...
(Date:12/8/2016)... ... 08, 2016 , ... With the increasing demand for dental implants, the National ... campaign to inform dentists and patients about the safety issues related to dental restorations. ... in the U.S. is projected to reach $6.4 billion in 2018 with more than ...
(Date:12/8/2016)... N.J. (PRWEB) , ... December 08, 2016 , ... ... delivery technologies and development solutions for drugs, biologics and consumer health products, today ... PSCI was set up in 2006 as a non-profit organization to unite pharmaceutical ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)... -- RxWiki Inc., a digital health company that powers the ... of pharmacies through its Digital Pharmacist SaaS platform, today ... on Fire" Award in the Health and Life Sciences ... award as one of Austin,s fastest growing companies," said ... "Our platform gives independent retail pharmacies the digital tools ...
(Date:12/9/2016)... Bermuda , Dec. 9, 2016  Axovant ... leading clinical-stage biopharmaceutical company focused on the treatment ... the data from a Phase 2b trial evaluating ... care donepezil, compared with donepezil plus placebo in ... that the addition of intepirdine to treatment was ...
(Date:12/8/2016)... Australia Ophthalmic Lasers Market Outlook to 2022 Summary ... to 2022", provides key market data on the Australia ... of US dollars, volume (in units) and average prices ... and YAG Lasers. The report also provides company ... market segements, and global corporate-level profiles of the key ...
Breaking Medicine Technology: